Rebecca A Hubbard
Affiliation: Group Health Cooperative
- The cumulative risk of false-positive fecal occult blood test after 10 years of colorectal cancer screeningRebecca A Hubbard
Group Health Research Institute Department of Biostatistics, School of Public Health, University of Washington and Group Health Permanente, Seattle, WA 98101, USA
Cancer Epidemiol Biomarkers Prev 22:1612-9. 2013..The objective of this study was to estimate the probability of experiencing a false-positive after receiving annual FOBT screening for 10 years...
- Evaluating components of dental care utilization among adults with diabetes and matched controls via hurdle modelsMonica Chaudhari
Washington Dental Service, 9706 Fourth Avenue NE, Seattle, WA 98115, USA
BMC Oral Health 12:20. 2012..This project had two purposes: to develop a methodology to estimate dental care utilization using claims data and to use this methodology to compare utilization of dental care between adults with and without diabetes...
- A semiparametric censoring bias model for estimating the cumulative risk of a false-positive screening test under dependent censoringRebecca A Hubbard
Biostatistics Unit, Group Health Research Institute, Seattle, Washington 98101, USA
Biometrics 69:245-53. 2013..Models that provide accurate estimates under dependent censoring are critical for providing appropriate information for evaluating screening tests...
- Diagnostic imaging and biopsy pathways following abnormal screen-film and digital screening mammographyRebecca A Hubbard
Group Health Research Institute, Group Health Cooperative, 1730 Minor Ave, Suite 1600, Seattle, WA 98101, USA
Breast Cancer Res Treat 138:879-87. 2013..To guide health systems in their efforts to eliminate practices that do not contribute to effective care, we need further research to identify the causes of this variation and the best evidence-based approach for follow-up...
- Effects of digital mammography uptake on downstream breast-related care among older womenRebecca A Hubbard
Group Health Research Institute, Group Health Cooperative, Department of Biostatistics, School of Public Health, University of Washington, Seattle, WA, USA
Med Care 50:1053-9. 2012..Digital mammography is the dominant modality for breast cancer screening in the United States. No previous studies have investigated as to how introducing digital mammography affects downstream breast-related care...
- Modelling the cumulative risk of a false-positive screening testRebecca A Hubbard
Group Health Research Institute, Biostatistics Unit and Department of Biostatistics, University of Washington, Seattle, WA 98101, USA
Stat Methods Med Res 19:429-49. 2010..The estimated risk of an FP recall after 10 screening mammograms varied between 58% and 77% depending on the approach used, with an estimate of 63% based on what we feel are the most reasonable modelling assumptions...
- Cumulative probability of false-positive recall or biopsy recommendation after 10 years of screening mammography: a cohort studyRebecca A Hubbard
Group Health Cooperative and School of Public Health of the University of Washington, Seattle, USA
Ann Intern Med 155:481-92. 2011..False-positive mammography results are common. Biennial screening may decrease the cumulative probability of false-positive results across many years of repeated screening but could also delay cancer diagnosis...
- Distinguishing screening from diagnostic mammograms using Medicare claims dataJoshua J Fenton
Departments of Family and Community Medicine, Radiology, and the Center for Healthcare Research and Policy, University of California Davis, Sacramento, CA Group Health Research Institute, Seattle, WA Departments of Radiology, Epidemiology and Biostatistics, University of California San Francisco, San Francisco, CA Department of Biostatistics, University of Washington, Seattle, WA
Med Care 52:e44-51. 2014..However, it is uncertain whether claims data can accurately distinguish screening from diagnostic mammograms, particularly when claims are not linked with cancer registry data...
- Mammographic screening interval in relation to tumor characteristics and false-positive risk by race/ethnicity and ageEllen S O'Meara
Group Health Research Institute, Seattle, Washington
Cancer 119:3959-67. 2013..Biennial screening mammography retains most of the benefits of annual breast cancer screening with reduced harms. Whether screening guidelines based on race/ethnicity and age would be more effective than age-based guidelines is unknown...
- Identification of abnormal screening mammogram interpretation using Medicare claims dataRebecca A Hubbard
Group Health Research Institute and Department of Biostatistics, University of Washington, 1730 Minor Ave, Suite 1600, Seattle, WA, 98101
Health Serv Res 50:290-304. 2015..To develop and validate Medicare claims-based approaches for identifying abnormal screening mammography interpretation...
- Classification accuracy of claims-based methods for identifying providers failing to meet performance targetsRebecca A Hubbard
Group Health Research Institute, Seattle, WA, U S A Department of Biostatistics, University of Washington, Seattle, WA, U S A
Stat Med 34:93-105. 2015..However, to achieve this potential, development of highly accurate claims-based outcome measures should remain a priority. Copyright © 2014 John Wiley & Sons, Ltd. ..
- Oral contraceptive use and bone density change in adolescent and young adult women: a prospective study of age, hormone dose, and discontinuationDelia Scholes
Group Health Research Institute, Group Health Cooperative, 1730 Minor Avenue, 16th Floor, Seattle, Washington 98101, USA
J Clin Endocrinol Metab 96:E1380-7. 2011..Oral contraceptive (OC) use is common, but bone changes associated with use of contemporary OC remain unclear...
- Prescription Opioids and Risk of Dementia or Cognitive Decline: A Prospective Cohort StudySascha Dublin
Group Health Research Institute, Seattle, Washington
J Am Geriatr Soc 63:1519-26. 2015..To determine whether prescription opioid use is associated with higher dementia risk or greater cognitive decline...
- Employee knowledge of value-based insurance design benefitsNora B Henrikson
Group Health Research Institute, Seattle, Washington Electronic address
Am J Prev Med 47:115-22. 2014..Value-based insurance designs (VBD) incorporate evidence-based medicine into health benefit design. Consumer knowledge of new VBD benefits is important to assessing their impact on health care use...